Concentration of synthetic compounds: Determining the levels of synthetic cannabinoids in biological samples such as blood or urine. Presence of different compounds: Detecting multiple compounds that may be present in the sample, helping to identify exposure. Health risk assessment: Analyzing the potential effects of the detected compounds on health, which helps doctors provide appropriate care. Monitoring illicit use: Supporting legal efforts to identify and track the use of these compounds in the community.

Individuals exposed to unknown substances: Those who exhibit symptoms related to synthetic cannabinoid use. Emergency patients: Such as cases of poisoning or unexplained mental confusion. Individuals undergoing drug testing: In workplace settings or during treatment programs. Patients experiencing unknown side effects: Such as psychological or physical disorders after using cannabinoid products. Frequent users of synthetic products: To monitor exposure levels and improve treatment management.

Mental confusion: Difficulty concentrating or disorientation. Mood changes: Such as severe anxiety, hallucinations, or depression. Physical disturbances: Like increased heart rate, high blood pressure, or nausea. Poisoning symptoms: Such as dizziness, loss of consciousness, or coordination problems. History of synthetic substance use: Anyone with a history of synthetic cannabinoid use or symptoms related to it.

What is the purpose of this test? The goal is to detect the presence of synthetic compounds in biological samples and assess exposure levels. How is the test performed? A blood or urine sample is collected and then analyzed using liquid chromatography and mass spectrometry techniques. Does the patient need special preparations before the test? Typically, no special preparations are required, but it is advisable to consult the doctor about any specific precautions. What is the ideal timing for the test? The test is best performed when symptoms related to synthetic compound use are present. How are the test results interpreted? The levels of detected compounds are compared with known values to determine whether they are elevated or abnormal. What are the risks associated with the test? The test is generally safe, with no significant risks associated with it. What do positive results mean? They may indicate the use of synthetic compounds, requiring further evaluation and appropriate treatment.

Negative results: Indicate the absence of synthetic cannabinoids in the sample, which is considered the normal condition. Positive results: Indicate the presence of synthetic cannabinoids, signaling exposure to these compounds.

Synthetic Cannabinoids Test | Lahalak Platform

Advanced LC-MS/MS analysis to detect synthetic cannabinoids with high precision, providing reliable and fast results to ensure safety and public health.

Prices starts from: 166.68 SAR

Scientific name: Synthetic Cannabinoids Test (LC-MS/MS)

Synthetic Cannabinoid Compounds analysis using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) is an advanced test used to identify and measure the levels of synthetic compounds that mimic the effects of cannabis in biological samples such as blood or urine. These compounds are commonly used in some recreational products and can cause ser...

Synthetic Cannabinoids Test (LC-MS/MS) - Synthetic Cannabinoids Test

Service type Laboratory Test (Blood/Urine)

Duration 10-15 minutes

Fasting Fasting is not required

Prices Starting from 166.68 SAR

Included Services

Synthetic Cannabinoid Compounds LC-MS/MS Test
The optimal health guidance based on the result.
Personal support services from Lahalak

Medical Service Information

Purpose Test

Concentration of synthetic compounds: Determining the levels of synthetic cannabinoids in biological samples such as blood or urine.
Presence of different compounds: Detecting multiple compounds that may be present in the sample, helping to identify exposure.
Health risk assessment: Analyzing the potential effects of the detected compounds on health, which helps doctors provide appropriate care.
Monitoring illicit use: Supporting legal efforts to identify and track the use of these compounds in the community.

Recommended groups

Individuals exposed to unknown substances: Those who exhibit symptoms related to synthetic cannabinoid use.
Emergency patients: Such as cases of poisoning or unexplained mental confusion.
Individuals undergoing drug testing: In workplace settings or during treatment programs.
Patients experiencing unknown side effects: Such as psychological or physical disorders after using cannabinoid products.
Frequent users of synthetic products: To monitor exposure levels and improve treatment management.

Symptoms indicative

Mental confusion: Difficulty concentrating or disorientation.
Mood changes: Such as severe anxiety, hallucinations, or depression.
Physical disturbances: Like increased heart rate, high blood pressure, or nausea.
Poisoning symptoms: Such as dizziness, loss of consciousness, or coordination problems.
History of synthetic substance use: Anyone with a history of synthetic cannabinoid use or symptoms related to it.

FAQs

What is the purpose of this test? The goal is to detect the presence of synthetic compounds in biological samples and assess exposure levels.
How is the test performed? A blood or urine sample is collected and then analyzed using liquid chromatography and mass spectrometry techniques.
Does the patient need special preparations before the test? Typically, no special preparations are required, but it is advisable to consult the doctor about any specific precautions.
What is the ideal timing for the test? The test is best performed when symptoms related to synthetic compound use are present.
How are the test results interpreted? The levels of detected compounds are compared with known values to determine whether they are elevated or abnormal.
What are the risks associated with the test? The test is generally safe, with no significant risks associated with it.

Normal Levels

Negative results: Indicate the absence of synthetic cannabinoids in the sample, which is considered the normal condition.
Positive results: Indicate the presence of synthetic cannabinoids, signaling exposure to these compounds.